EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:77069 - eperisone
| ChEBI ID | CHEBI:77069 |
| ChEBI Name | eperisone |
| Stars | |
| Definition | A racemate that is an equimolar mixture of (R)- and (S)-eperisone. It is used (as the hydrochloride salt) as a muscle relaxant for the symptomatic treatment of muscle spasm and spasticity. |
| Last Modified | 22 February 2017 |
| Submitter | Gareth Owen |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Application: | muscle relaxant A drug used to produce muscle relaxation (excepting neuromuscular blocking agents). Its primary clinical and therapeutic use is the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. Also used for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in multiple sclerosis. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| eperisone (CHEBI:77069) has part (R)-eperisone (CHEBI:77071) |
| eperisone (CHEBI:77069) has part (S)-eperisone (CHEBI:77072) |
| eperisone (CHEBI:77069) has role muscle relaxant (CHEBI:51371) |
| eperisone (CHEBI:77069) is a racemate (CHEBI:60911) |
| IUPAC Name |
|---|
| rac-1-(4-ethylphenyl)-2-methyl-3-(piperidin-1-yl)propan-1-one |
| INNs | Source |
|---|---|
| eperisonum | WHO MedNet |
| eperisona | WHO MedNet |
| épérisone | WHO MedNet |
| eperisone | WHO MedNet |
| Synonyms | Source |
|---|---|
| (±)-eperisone | ChemIDplus |
| 4'-ethyl-2-methyl-3-piperidinopropiophenone | ChemIDplus |
| 1-(4-ethylphenyl)-2-methyl-3-(1-piperidinyl)-1-propanone | ChemIDplus |
| Citations |
|---|